Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

RPCI enrolls patients in clinical trials of immunotherapy approaches for treating genitourinary cancers

RPCI enrolls patients in clinical trials of immunotherapy approaches for treating genitourinary cancers

Anastrozole drug: An effective new option for breast cancer prevention for postmenopausal women

Anastrozole drug: An effective new option for breast cancer prevention for postmenopausal women

HCV antiviral therapy also improves diabetes outcomes

HCV antiviral therapy also improves diabetes outcomes

Low sodium levels linked to poor targeted therapy outcomes in RCC

Low sodium levels linked to poor targeted therapy outcomes in RCC

Early tumor shrinkage predicts targeted therapy efficacy in RCC

Early tumor shrinkage predicts targeted therapy efficacy in RCC

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Navidea receives Fast Track designation for Lymphoseek injection

Navidea receives Fast Track designation for Lymphoseek injection

Nanostring Technologies announces nationwide availability of Prosigna Breast Cancer Assay in 2014

Nanostring Technologies announces nationwide availability of Prosigna Breast Cancer Assay in 2014

Genetic deficiency in males can trigger hepatocellular carcinoma, type 2 diabetes

Genetic deficiency in males can trigger hepatocellular carcinoma, type 2 diabetes

Study helps explain why survival gap persists for African-Americans with head and neck cancer

Study helps explain why survival gap persists for African-Americans with head and neck cancer

Increased levels of protein HSET linked with worse breast cancer outcomes in African-Americans

Increased levels of protein HSET linked with worse breast cancer outcomes in African-Americans

Study: Ethnic groups with high prevalence of diabetes have high hepatocellular carcinoma rates

Study: Ethnic groups with high prevalence of diabetes have high hepatocellular carcinoma rates

MassBiologics gets FDA orphan drug designation for MBL-HCV1 antibody

MassBiologics gets FDA orphan drug designation for MBL-HCV1 antibody

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

Smoking reduces nasopharyngeal cancer survival

Smoking reduces nasopharyngeal cancer survival

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.